Skip to main content
Top

Calcified Tissue International

Issue 1/2013

Content (10 Articles)

Original Research

No Reduction in Circulating Preosteoclasts 18 Months after Treatment with Zoledronate: Analysis from a Randomized Placebo Controlled Trial

Nicola Dalbeth, Bregina Pool, Angela Stewart, Anne Horne, Meaghan E. House, Jillian Cornish, Ian R. Reid

Original Research

Effects of Strontium Ranelate Administration on Calcium Metabolism in Female Patients with Postmenopausal Osteoporosis and Primary Hyperparathyroidism

Vincenzo Carnevale, Romano Del Fiacco, Elisabetta Romagnoli, Andrea Fontana, Cristiana Cipriani, Jessica Pepe, Salvatore Minisola

Original Research

Neurofibromatosis 1-Related Osteopenia Often Progresses to Osteoporosis in 12 Years

Eetu Heervä, Pekka Leinonen, Tommi Kuorilehto, Sirkku Peltonen, Minna Pöyhönen, Kalervo Väänänen, Juha Peltonen

Open Access Original Research

High Beta-Palmitate Formula and Bone Strength in Term Infants: A Randomized, Double-Blind, Controlled Trial

Ita Litmanovitz, Keren Davidson, Alon Eliakim, Rivka H. Regev, Tzipora Dolfin, Shmuel Arnon, Fabiana Bar-Yoseph, Amit Goren, Yael Lifshitz, Dan Nemet

Original Research

Assessing the Impact of Osteoporosis on the Burden of Hip Fractures

Anders Odén, Eugene V. McCloskey, Helena Johansson, John A. Kanis

Open Access Original Research

A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data

Michael R. McClung, Claude-Laurent Benhamou, Zulema Man, Witold Tlustochowicz, Jose R. Zanchetta, Rachelle Eusebio, Ana M. Balske, Ellen Matzkin, Wojciech P. Olszynski, Robert Recker, Pierre D. Delmas

Original Research

Optimal Serum Concentration of 25-Hydroxyvitamin D for Bone Health in Older Korean Adults

You-Cheol Hwang, Hong-Yup Ahn, In-Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.